ArticleDisease markers2022

Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Cancer Patients Undergoing Immune Checkpoint Inhibitors.

Luying Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.